Skip to main content
Log in

131I gastric uptake with and without omeprazole in patients undergoing radioiodine therapy for differentiated thyroid carcinoma

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WJ, et al. Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2008;35(10):1941–59.

    Article  PubMed  CAS  Google Scholar 

  2. Richardson P, Hawkey C, Stack W. Proton pump inhibitors – pharmacology and rationale for use in gastrointestinal disorders. Drugs. 1998;56(3):307–35.

    Article  PubMed  CAS  Google Scholar 

  3. Ford PV, Bartold SP, Fink-Bennett DM, Jolles PR, Lull RJ, Maurer AH, et al. Society of Nuclear Medicine Procedure Guideline for gastrointestinal bleeding and Meckel’s diverticulum scintigraphy. Reston, VA: Society of Nuclear Medicine; 1999. p. 45–52.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patricio González.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Castro, G., Berrocal, I., Carmona, J. et al. 131I gastric uptake with and without omeprazole in patients undergoing radioiodine therapy for differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging 39, 1356–1357 (2012). https://doi.org/10.1007/s00259-012-2104-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-012-2104-1

Keywords

Navigation